syringaresinol has been researched along with Skin Aging in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Joo, YH; Karadeniz, F; Ko, J; Kong, CS; Oh, JH | 1 |
| Cho, S; Izuo, N; Kim, J; Ozawa, Y; Seo, DB; Shibuya, S; Shimizu, T; Toda, T; Watanabe, K; Yokote, K | 1 |
2 other study(ies) available for syringaresinol and Skin Aging
| Article | Year |
|---|---|
Syringaresinol Inhibits UVA-Induced MMP-1 Expression by Suppression of MAPK/AP-1 Signaling in HaCaT Keratinocytes and Human Dermal Fibroblasts.
Topics: Collagen; Enzyme-Linked Immunosorbent Assay; Fibroblasts; Furans; HaCaT Cells; Humans; Inflammation; Keratinocytes; Lignans; MAP Kinase Signaling System; Matrix Metalloproteinase 1; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Skin; Skin Aging; Transcription Factor AP-1; Ultraviolet Rays | 2020 |
Syringaresinol Reverses Age-Related Skin Atrophy by Suppressing FoxO3a-Mediated Matrix Metalloproteinase-2 Activation in Copper/Zinc Superoxide Dismutase-Deficient Mice.
Topics: Animals; Atrophy; Biopsy, Needle; Blotting, Western; Copper; Forkhead Box Protein O3; Furans; Immunohistochemistry; Lignans; Matrix Metalloproteinase 2; Mice; Mice, Hairless; Polymerase Chain Reaction; Skin Aging; Superoxide Dismutase; Superoxide Dismutase-1; Treatment Outcome | 2019 |